Literature DB >> 11472398

Direct B/B-cell interactions in immunoglobulin synthesis.

K Shinozaki1, K Yasui, K Agematsu.   

Abstract

The principal roles of B/B-cell interactions in immune response have not yet been established. We therefore investigated B/B-cell interactions in immunoglobulin synthesis via direct cell-to-cell contact, particularly in the tumour necrosis factor receptor (TNFR)/tumour necrosis factor (TNF) family. We prepared highly purified peripheral blood B cells and stimulated them with Epstein--Barr virus (EBV)-transformed B lymphoblastoid cell lines (LCLs) as activated human B cells. The IgG production by B cells was increased by the addition of fixed LCLs in a dose-dependent manner in the presence of IL-10 plus IL-2. LCLs strongly expressed CD40 and CD70 on their surface, but marginal or no CD154, CD27, OX40 (CD134) and CD134 ligand. The enhancement of immunoglobulin production by LCLs was completely blocked by the initial addition of anti-CD70 blocking MoAb, but not by anti-CD154 or anti-CD134 ligand MoAb. The addition of LCLs also caused a reduction in CD27 expression on B cells, and this effect was completely blocked by anti-CD70 MoAb, indicating a direct B cell--LCL contact via CD27/CD70. LCLs markedly promoted B-cell differentiation into plasma cells in the presence of IL-10 plus IL-2. These findings demonstrate that direct interactions between B and B cells via CD27/CD70 induce immunoglobulin production by promoting the generation of plasma cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472398      PMCID: PMC1906067          DOI: 10.1046/j.1365-2249.2001.01518.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses.

Authors:  S Morimoto; Y Kanno; Y Tanaka; Y Tokano; H Hashimoto; S Jacquot; C Morimoto; S F Schlossman; H Yagita; K Okumura; T Kobata
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

2.  CD27 expression by a distinct subpopulation of human B lymphocytes.

Authors:  D Maurer; W Holter; O Majdic; G F Fischer; W Knapp
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

3.  The 1A4 molecule (CD27) is involved in T cell activation.

Authors:  K Sugita; Y Torimoto; Y Nojima; J F Daley; S F Schlossman; C Morimoto
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

4.  CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells.

Authors:  H Nagumo; K Agematsu; K Shinozaki; S Hokibara; S Ito; M Takamoto; T Nikaido; K Yasui; Y Uehara; A Yachie; A Komiyama
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

5.  Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen.

Authors:  R A van Lier; J Borst; T M Vroom; H Klein; P Van Mourik; W P Zeijlemaker; C J Melief
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

6.  Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor.

Authors:  R G Goodwin; M R Alderson; C A Smith; R J Armitage; T VandenBos; R Jerzy; T W Tough; M A Schoenborn; T Davis-Smith; K Hennen
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

7.  Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens.

Authors:  M Streuli; C Morimoto; M Schrieber; S F Schlossman; H Saito
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

8.  Cloned and expressed human Fc receptor for IgG mediates anti-CD3-dependent lymphoproliferation.

Authors:  G A Peltz; M L Trounstine; K W Moore
Journal:  J Immunol       Date:  1988-09-15       Impact factor: 5.422

9.  Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion.

Authors:  M K Spriggs; R J Armitage; L Strockbine; K N Clifford; B M Macduff; T A Sato; C R Maliszewski; W C Fanslow
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

10.  The proteins encoded by the VpreB and lambda 5 pre-B cell-specific genes can associate with each other and with mu heavy chain.

Authors:  H Karasuyama; A Kudo; F Melchers
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  8 in total

1.  In situ trans ligands of CD22 identified by glycan-protein photocross-linking-enabled proteomics.

Authors:  T N C Ramya; Eranthie Weerapana; Lujian Liao; Ying Zeng; Hiroaki Tateno; Liang Liao; John R Yates; Benjamin F Cravatt; James C Paulson
Journal:  Mol Cell Proteomics       Date:  2010-02-19       Impact factor: 5.911

2.  Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia.

Authors:  A Stray-Pedersen; I S Aaberge; A Früh; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

3.  Involvement of CD27/CD70 interactions in antigen-specific cytotoxic T-lymphocyte (CTL) activity by perforin-mediated cytotoxicity.

Authors:  S Yamada; K Shinozaki; K Agematsu
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

4.  Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID).

Authors:  C Groth; R Drager; K Warnatz; G Wolff-Vorbeck; S Schmidt; H Eibel; M Schlesier; H-H Peter
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

5.  Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.

Authors:  Amrie C Grammer; Rebecca Slota; Randy Fischer; Hanan Gur; Hermann Girschick; Cheryl Yarboro; Gabor G Illei; Peter E Lipsky
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 6.  Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome.

Authors:  Thomas Dörner; Peter E Lipsky
Journal:  Arthritis Res       Date:  2002-09-25

Review 7.  The CD70-CD27 axis in oncology: the new kids on the block.

Authors:  Tal Flieswasser; Astrid Van den Eynde; Jonas Van Audenaerde; Jorrit De Waele; Filip Lardon; Carsten Riether; Hans de Haard; Evelien Smits; Patrick Pauwels; Julie Jacobs
Journal:  J Exp Clin Cancer Res       Date:  2022-01-06

Review 8.  B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue.

Authors:  Arne Hansen; Peter E Lipsky; Thomas Dörner
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.